Osseon Receives Second Patent Allowance for Minimally Invasive Vertebral Compression Fracture Treatme... ( SANTA ROSA Calif. Oct. 4 /- Osseon Th...)

Osseon Receives Second Patent Allowance for Minimally Invasive Vertebral Compression Fracture Treatment Devices

Date:10/4/2010

SANTA ROSA, Calif., Oct. 4 /PRNewswire/ -- Osseon Therapeutics, Inc., a biomedical device company based in Santa Rosa, California, received its second patent Notice of Allowance (NOA) for its spinal vertebral compression fracture (VCF) technology. The company, which was started in 2006, now has two allowed and twelve additional patent applications pending in the United States, and several others throughout the world for spinal therapies and devices.

The company has been marketing its FDA and CE Mark cleared "Osseoplasty™" system in the U.S. and Europe, since February, 2009 and February, 2010, respectively. The proprietary Osseoplasty™ procedure has been performed in over 1,100 patients in the U.S. and Europe.

According to John Stalcup, Ph.D., President and CEO of Osseon, "This second patent allowance for Osseon's spinal VCF technology is another cornerstone for the company's intellectual property foundation. We continue to strengthen our intellectual property position and strive to obtain additional patents in the future on various aspects of the Osseoflex® steerable and curvable needle and the novel methods for bone cement delivery, which enable a safe, effective, and minimally invasive approach for spine disease treatment."

ABOUT Osseon Therapeutics, Inc.

About Osseon

Osseon Therapeutics, Inc. focuses on bringing to market alternative minimally invasive treatments for degenerative bone and joint disease. Headquartered in Santa Rosa, CA, the company's groundbreaking technology and delivery system provides comparable or better efficacy and safety than other commercial solutions while offering significant advantages in efficiency and cost. By improving the treatment of compression fractures within the thoracic and lumbar vertebral spine, Osseon offers alternative solutions to patients suffering from these maladies, as well as the physicians and medical facilities that tre
'/>"/>

SOURCE Osseon Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Osseon Receives Patent Allowance for Novel Spinal VCF Treatment Devices
2. Osseon Therapeutics Demonstrates to the European Medical Community How to Think Outside The Balloon When Treating Vertebral Compression Fractures
3. Osseon Launches in Europe
4. Prognosis Health Information Systems ChartAccess 4.0 Receives ONC-ATCB 2011/2012 Certification
5. Mylan Receives Approval for Fludarabine Phosphate Injection, USP
6. WATCHMAN® Receives German Reimbursement Coverage
7. Lingohocken Fire Company Receives PAD Donation After Recent Rescue at Fox Heath Farm
8. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
9. Advanced Life Sciences Receives $1.5 Million From Exercise of Unit Warrants and Secures Financing Commitment
10. China Shenghuo Receives Notice from NYSE Amex LLC Regarding Listing Standards
11. Progenika Receives CE Mark for First DNA Chip to Detect Mutations in Lipoprotein Lipase (LPL) Gene

Post Your Comments:

(Date:5/20/2013)... LONDON , BERLIN and ... -- Arthroscopy Devices Market to 2018 ... Minimally Invasive Procedures to Drive Future Growth" looks at ... the six arthroscopy device market segments: arthroscopes, arthroscopy shavers, ... frequency systems, and arthroscopy visualization systems. The report provides ...

(Date:5/20/2013)... 2013 Neuralstem, Inc. (NYSE MKT: CUR) today reported ... principal investigator, presented updated Phase I data from its ... the treatment of amyotrophic lateral sclerosis (ALS or ... diabetes special medical symposium in Bucharest, Romania ... Therapeutic Advances in Stem Cell Therapy," Dr. Feldman outlined ...

(Date:5/20/2013)... , May 20, 2013 With herbal ... resource available from the U.S. Pharmacopeial Convention (USP) will ... quality of the herbal ingredients used in these products. ... included in the new Herbal Medicines Compendium ... worldwide at hmc.usp.org . HMC ...

Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2 Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3 Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3 Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4 New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 2 New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines 3

[0] Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth [0] Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania [0] New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines

... Reportlinker.com announces that a new market research report ... Nephrology and Urology Devices Market Outlook to 2017 ... and Urology Devices Market Outlook to 2017 ... Nephrology and Urology Devices Market Outlook to 2017" provides ...

... Reportlinker.com announces that a new market research ... Continuous Glucose Monitoring (CGM) Systems ... Market Forecasts to 2016 ... Monitoring (CGM) Systems - Global Pipeline Analysis, ...

Reportlinker Adds Europe Nephrology and Urology Devices Market Outlook to 2017 Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

(Date:5/20/2013)... May 2013 While Huntington,s disease (HD) is ... new disease-modifying therapies in development may slow or ... research depends upon the identification of reliable and ... and these biomarkers may eventually be used as ... especially helpful to monitor changes during the time ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 ... adult allogeneic stem cell manufacturing, research and development, ... of Medicine and Director of Interventional Cardiology Research ... join the Scientific and Medical Advisory Board for ... of Pennsylvania, Dr. Wilensky divides his time between ...

(Date:5/20/2013)... of the much-anticipated Second Edition of The Biology of ... Edition has been hailed as an incomparable classic. Thoroughly ... fast-growing field of cancer biology, The Biology of Cancer, ... by students, instructors, researchers, and clinicians around the world. ... students studying the molecular and cellular bases of cancer ...

(Date:5/20/2013)... MONDAY, May 20 (HealthDay News) -- Boys who are ... likely to become obese adults as those who didn,t ... 30-year study shows. Researchers found that men with ... (BMI) and obesity, even if they no longer had ... well-off or poor, they tended toward obesity. "The ...

(Date:5/20/2013)... NY (PRWEB) May 20, 2013 In ... of the numerous scientific accomplishments achieved at The ... group of female scientists, Advancing Women in Science ... breakfast on May 17. Scientists, educators, business and ... celebrate excellence and achievements of women in science. ...

Breaking Medicine News(10 mins):Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 2 Health News:Leading researchers report on the elusive search for biomarkers in Huntington's disease 3 Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 2 Health News:Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board 3 Health News:'The Biology of Cancer' by Robert A. Weinberg 2 Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 2 Health News:ADHD in Childhood May Raise Risk for Obesity in Adulthood 3 Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 2 Health News:North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week 3

[0] Leading researchers report on the elusive search for biomarkers in Huntington's disease [0] Noted Cardiologist Robert Wilensky to Join Stemedica Cardiology Division Scientific & Medical Advisory Board [0] 'The Biology of Cancer' by Robert A. Weinberg [0] ADHD in Childhood May Raise Risk for Obesity in Adulthood [0] North Shore-LIJ's Feinstein Institute Celebrates Women in Science During National Women’s Health Week

... can do a lot to keep kids safe, experts say, , ... to be), youngsters are probably going to be spending less ... doing cannonballs. , It,s all fun and games -- until someone ... warn child safety experts. , Though many injuries amount to little ...

... Invited to Attend , , NEW ORLEANS, June 6 ... New Orleans for the 2009 Catholic Health Assembly, "In Our ... , The assembly, hosted by the Catholic Health Association of ... Catholic health care leaders from across the nation. They come ...

... ... Low Vision Conditions , ... Beach, CA (PRWEB) June 6, 2009 -- Enhanced Vision , America,s leading manufacturer of ... VISION 5K Run & Walk in Boston, MA this Saturday, June 7th. The unique event ...

... , - These acquisitions reinforce Genomma Lab,s presence in the cosmetics ... lotions and perfumes segments , , - Genomma Lab continues ... place in June 2008 , , ... C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), one of ...

... study found diabetes drug didn,t increase chances of heart disease, ... drug Avandia significantly raises the risk of both heart failure ... for either cardiovascular disease or death, new research has found. ... risk of death, said the authors of the much-anticipated RECORD ...

... June 5 NxStage Medical, Inc. (Nasdaq: ... today announced it has completed the closing of its ... alliance partner, Asahi Kasei Kuraray Medical. The Company used ... its entire debt obligation, including prepayment and other transaction ...

Cached Medicine News:Health News:Summer Fun Need Not Be Hazardous 2 Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 2 Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 3 Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 2 Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 3 Health News:Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns 2 Health News:Avandia Raises Risk of Heart Failure, Fractures 2 Health News:Avandia Raises Risk of Heart Failure, Fractures 3 Health News:Avandia Raises Risk of Heart Failure, Fractures 4 Health News:NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical 2

Summer Fun Need Not Be Hazardous 2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns Avandia Raises Risk of Heart Failure, Fractures NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical

The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...

The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...

... Arthroscopy Scissor is ideal for excising soft tissue ... in the joint. The serrated edge on the ... as hold tissue within the jaws for more ... right jaw curvatures, are the perfect tools for ...

... The Series I Instrument program offers state-of-the-art ... profile, while maintaining strength and durability. Low ... in tight joint spaces. Series I instruments ... tip style, size and angle required for ...

Medicine Products:

Bioabsorbable (PLLA) Wedge Interference Screws Shoulder Instrumentation System Scissor, Right Curved Tip, 3.4 mm Straight Shaft Punch, Rotary with Scoop 90 Right Tip, 3.4 mm Straight Shaft